Flu Scan for Oct 01, 2015

News brief
Topics
Avian Influenza (Bird Flu)
Influenza Vaccines
Pandemic Influenza

HHS funds 2 projects to aid flu vaccine development

The Department of Health and Human Services (HHS) is funding two projects to aid in developing better seasonal flu vaccines and in improving pandemic flu preparedness, the agency said in a news release yesterday.

One project advances the development of a novel oral influenza vaccine taken in pill form that could generate broader types of immune responses, and the other is a data-driven tool to inform experts in selecting more effective flu vaccines for the nation's pre-pandemic stockpile. Both will be funded by HHS's Office of the Assistant Secretary for Preparedness and Response through its Biomedical Advanced Research and Development Authority (BARDA).

BARDA has awarded a 2-year, $14 million contract to support the development of a room-temperature–stable, oral recombinant candidate flu vaccine made by Vaxart Inc. of San Francisco. The contract funds clinical studies comparing the oral vaccine to a licensed inactivated flu vaccine.

Earlier clinical studies indicated that the oral vaccine might elicit immune responses associated with protection against multiple seasonal flu viruses and those with pandemic potential, according to the release, apparently referring to a phase 1 trial published about a month ago in The Lancet Infectious Diseases. That study involved 24 adults, 12 of whom received the vaccine.

BARDA also will provide $8 million, with an option for a total of $24.3 million over 5 years, for the University of Cambridge in the United Kingdom to develop methods of antigenic mapping, or forecasting how flu viruses might change over time. The approach could improve a vaccine's match to evolving H5N1 and other potential pandemic flu viruses, HHS said.
Sep 30 HHS press release
Sep 6 Lancet Infect Dis study

 

H5N6 detected again in Vietnamese poultry

Vietnam's agriculture ministry yesterday reported another highly pathogenic H5N6 avian flu outbreak. The latest outbreak began on Sep 29, striking backyard birds in a village in Lai Chau province, located in the far northern part of Vietnam, according to a report to the World Organization for Animal Health (OIE).

Of 1,005 susceptible birds, the virus killed 801, and the remaining ones were stamped out to control the spread of the disease.

Vietnam has had a host of H5N6 outbreaks since August 2014, when the virus was first detected there and identified as a new strain.
Sep 30 OIE report

News Scan for Oct 01, 2015

News brief
Topics
Ebola
Viral Hemorrhagic Fever
Public Health
Business Preparedness
Pandemic Influenza
Legionella

BARDA exercises $18 million option for Ebola vaccine

NewLink Genetics today announced that the federal government has exercised an $18 million option to ramp up the production of its experimental Ebola vaccine VSV-EBOV, according to a statement from the company. The company has licensed the vaccine from the Public Health Agency of Canada, the developer of the vaccine, which is furthest along in clinical studies in the West African outbreak region.

The additional funding comes on top of a $30 million contract awarded at the end of 2014 by the Biomedical Advanced Research and Development Authority (BARDA), part of the US Department of Health and Human Services (HHS). NewLink, based in Ames, Iowa, in late 2014 licensed the vaccine to Merck to speed its development.

Charles Link, the company's chief executive officer and chief scientific officer, said the additional funding will help the two companies accelerate large-scale manufacturing of VSV-EBOV and shows federal commitment to the important project. "In collaboration with Merck, we will continue to work diligently to bring this vaccine candidate to patients in need as quickly as possible." A ring vaccination trial in Guinea recently reported good results, and the vaccine is being used in both Guinea and Sierra Leone to vaccinate contacts of new cases.

Today's announcement is the federal government's second in a week for VSV-EBOV. On Sep 24 the company announced that it had received an $8.1 million award from the Defense Threat Reduction Agency (DTRA), part of the US Department of Defense, to support the development of the vaccine. That contract came with a $5.2 million option to support future development.
Oct 1 NewLink genetics press release
Sep 28 CIDRAP News scan "Sierra Leone begins Ebola-free countdown"

 

HHS launches disaster preparedness resource system

HHS yesterday unveiled a resource system designed to help communities prepare for and manage health issues related to disasters.

Under the acronym TRACIE (technical resources, assistance center, and information exchange), the resource system sponsored by HHS's Assistant Secretary for Preparedness and Response (ASPR) includes resource materials, a help line, just-in-time suggestions, and information-sharing tools learned from previous disaster experiences.

Nicole Lurie, MD, MPH, ASPR at HHS, said in a statement yesterday, "TRACIE can help health and emergency management officials across the country learn about, share, and apply best practices and experiences before, during, and after disasters to protect health and potentially save lives."

An expert group helped ASPR identify the needs of public health and medical systems, and the new system represents collaboration between stakeholders at many levels, from federal to nongovernmental, the agency said. HHS added that registration is free, and users can get advice from hundreds of health, disaster medicine, and public health experts and rate the usefulness and access to the resources.
Sep 30 HHS press release
TRACIE Web portal

 

Bronx Legionnaire's outbreak grows to 13 cases, 1 death

An outbreak of Legionella infections has increased to 13 cases in the Bronx, with 1 death, while the bacterium has been detected in cooling towers in two Long Island high schools, according to media reports.

All patients have underlying conditions, USA Today reported yesterday. Nine of them remain hospitalized and three have been released, the office of New York City Mayor Bill de Blasio said yesterday.

The legionellosis outbreak is not as serious as one in South Bronx in the summer, which sickened 128 and killed 12 people, the story said. The current outbreak is in the Morris Park neighborhood. There have been no new cases in the past 9 days, de Blasio's office said.

In related news, two cooling towers in Smithtown, near Stony Brook on Long Island have tested positive for Legionella, according to a CBSNewYork/AP report. Cooling towers at Smithtown East and Smithtown West high schools both had evidence of the bacterium.

No cases have been reported in that school district, the story said.
Sep 30 USA Today story
Oct 1 CBSNewYork/AP report

This week's top reads

  1. FDA significantly limits COVID-19 vaccine recommendations

    Critics said today’s announcement is more evidence of the current administration’s willingness to undermine public trust in vaccines.

    Stephanie Soucheray
    FDA building

  2. Woman dies of Creutzfeldt-Jakob almost 50 years after taking prion-contaminated growth hormone

    The patient, who presented with gait imbalance and tremors, wasn't diagnosed until she was in a coma, shortly before she died.

    Mary Van Beusekom
    Woman in hospital bed

  3. HHS expected to discontinue COVID vaccine recommendations for some groups

    When CDC advisers widened their recommendation in 2023, most members were swayed by data, including those for long COVID, showing that no group is at low risk for the virus.

    Lisa Schnirring

  4. WHO advisers say current strains OK for COVID vaccine production

    Current vaccine strains show high neutralization against the latest variants, but the LP.8.1 antigen may provide similar or moderately higher cross-reactive antibody response.

    Lisa Schnirring
    senior vaccination

  5. US measles outbreak grows to 1,024 cases

    Texas remains the country's hot spot, with 718 cases. 

    Chris Dall
    Doctor treating child with measles

  6. Moderna pulls licensing submission for combo flu-COVID vaccine

    Moderna's combination vaccine was intended for adults 50 and older. 

    Stephanie Soucheray

  7. Mpox activity escalates in Sierra Leone

    Responding to the surge is a major focus, partly to prevent the spread to other West African countries. 

    Lisa Schnirring
    mpox virus

  8. FDA vaccine advisers recommend sticking with JN.1 strain for next COVID vaccines

    The group weighed considerations about newer variants and raised concerns that a strain recommendation might interface with the FDA's new proposed COVID vaccine framework.

    Lisa Schnirring
    woman vaccinated

  9. Viewpoint: Making key COVID vaccine decisions without input, transparency is a public disservice

    Newly announced rules that limit the use of COVID vaccines suggest that federal officials are opposed to open discussion and transparency.

    Vaccine Integrity Project Staff and Advisers
    COVID vaccine vial and syringe

  10. 'A national scandal': US excess deaths rose even after pandemic, far outpacing peer countries

    The United States has been in a "protracted health crisis" for decades, the researchers say.

    Mary Van Beusekom
    Grave markers with flowers

Our underwriters